Penumbra Inc
NYSE:PEN
Penumbra Inc
Revenue
Penumbra Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Penumbra Inc
NYSE:PEN
|
Revenue
$1.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Penumbra Inc
Revenue Breakdown
Breakdown by Geography
Penumbra Inc
Total Revenue:
1.1B
USD
|
United States:
757.2m
USD
|
International:
301.4m
USD
|
Breakdown by Segments
Penumbra Inc
Total Revenue:
1.1B
USD
|
Thrombectomy:
677.3m
USD
|
Embolization And Other:
381.2m
USD
|
See Also
What is Penumbra Inc's Revenue?
Revenue
1.1B
USD
Based on the financial report for Dec 31, 2023, Penumbra Inc's Revenue amounts to 1.1B USD.
What is Penumbra Inc's Revenue growth rate?
Revenue CAGR 5Y
19%
Over the last year, the Revenue growth was 25%. The average annual Revenue growth rates for Penumbra Inc have been 24% over the past three years , 19% over the past five years .